{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:20:02Z","timestamp":1795094402035,"version":"4.10.2"},"reference-count":247,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730030"],"award-info":[{"award-number":["81730030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81621062"],"award-info":[{"award-number":["81621062"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Oral Sci"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Periodontitis is an inflammatory disease involving the destruction of both soft and hard tissue in the periodontal region. Although dysbiosis of the local microbial community initiates local inflammation, over-activation of the host immune response directly activates osteoclastic activity and alveolar bone loss. Many studies have reported on the cytokine network involved in periodontitis and its crucial and pleiotropic effect on the recruitment of specific immunocytes, control of pathobionts and induction or suppression of osteoclastic activity. Nonetheless, particularities in the stimulation of pathogens in the oral cavity that lead to the specific and complex periodontal cytokine network are far from clarified. Thus, in this review, we begin with an up-to-date aetiological hypothesis of periodontal disease and summarize the roles of cytokines in the host immune response. In addition, we also summarize the latest cytokine-related therapeutic measures for periodontal disease.<\/jats:p>","DOI":"10.1038\/s41368-019-0064-z","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T20:05:40Z","timestamp":1572897940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":624,"title":["The cytokine network involved in the host immune response to periodontitis"],"prefix":"10.1038","volume":"11","author":[{"given":"Weiyi","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"key":"64_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nri3785","volume":"15","author":"G Hajishengallis","year":"2015","unstructured":"Hajishengallis, G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol. 15, 30\u201344 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"64_CR2","unstructured":"Feng, X. Oral health of Chinese residents: report of the fourth China oral health epidemiological investigation. in Compilation of the 18th Annual Academic Conference of Oral Preventive Medicine (Chinese Stomatological Association, 2018)."},{"key":"64_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/prd.12181","volume":"75","author":"G Hajishengallis","year":"2017","unstructured":"Hajishengallis, G. & Korostoff, J. M. Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later. Periodontol 2000 75, 116\u2013151 (2017).","journal-title":"Periodontol 2000"},{"key":"64_CR4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1902\/jop.2015.140520","volume":"86","author":"PI Eke","year":"2015","unstructured":"Eke, P. I. et al. Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012. J. Periodontol. 86, 611\u2013622 (2015).","journal-title":"J. Periodontol."},{"key":"64_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrcardio.2010.120","volume":"7","author":"RJ Genco","year":"2010","unstructured":"Genco, R. J. & Van Dyke, T. E. Prevention: reducing the risk of CVD in patients with periodontitis. Nat. Rev. Cardiol. 7, 479\u2013480 (2010).","journal-title":"Nat. Rev. Cardiol."},{"key":"64_CR6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1177\/0022034510375281","volume":"89","author":"AM Kebschull","year":"2010","unstructured":"Kebschull, A. M., Demmer, R. T. & Papapanou, P. N. \u201cGum bug, leave my heart alone!\u201d\u2014epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J. Dent. Res. 89, 879\u2013902 (2010).","journal-title":"J. Dent. Res."},{"key":"64_CR7","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nrendo.2011.106","volume":"7","author":"E Lalla","year":"2011","unstructured":"Lalla, E. & Papapanou, P. N. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat. Rev. Endocrinol. 7, 738\u2013748 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"64_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrrheum.2010.139","volume":"6","author":"K Lundberg","year":"2010","unstructured":"Lundberg, K., Wegner, N., Yucel-Lindberg, T. & Venables, P. J. Periodontitis in RA\u2014the citrullinated enolase connection. Nat. Rev. Rheumatol. 6, 727\u2013730 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"64_CR9","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1111\/jcpe.12082","volume":"40","author":"PN Madianos","year":"2013","unstructured":"Madianos, P. N., Bobetsis, Y. A. & Offenbacher, S. Adverse pregnancy outcomes (APOs) and periodontal disease: pathogenic mechanisms. J. Periodontol. 40, S170\u2013S180 (2013).","journal-title":"J. Periodontol."},{"key":"64_CR10","first-page":"70","volume":"19","author":"WJ Loesche","year":"1992","unstructured":"Loesche, W. J. The specific plaque hypothesis and the antimicrobial treatment of periodontal disease. Dent. Update 19, 70\u201372 (1992).","journal-title":"Dent. Update"},{"key":"64_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.3336774","volume":"239","author":"SC Holt","year":"1988","unstructured":"Holt, S. C., Ebersole, J., Felton, J., Brunsvold, M. & Kornman, K. S. Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science 239, 55\u201357 (1988).","journal-title":"Science"},{"key":"64_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1600-051X.1998.tb02419.x","volume":"25","author":"SS Socransky","year":"1998","unstructured":"Socransky, S. S., Haffajee, A. D., Cugini, M. A., Smith, C. & Kent, R. L. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25, 134\u2013144 (1998).","journal-title":"J. Clin. Periodontol."},{"key":"64_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrmicro2337","volume":"8","author":"RP Darveau","year":"2010","unstructured":"Darveau, R. P. Periodontitis: a polymicrobial disruption of host homeostasis. Nat. Rev. Microbiol. 8, 481\u2013490 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"64_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.2041-1014.2011.00612.x","volume":"26","author":"RH Orth","year":"2011","unstructured":"Orth, R. H., O\u2019Brien\u2010Simpson, N. M., Dashper, S. G. & Reynolds, E. C. Synergistic virulence of Porphyromonas gingivalis and Treponema denticola in a murine periodontitis model. Mol. Oral. Microbiol 26, 229\u2013240 (2011).","journal-title":"Mol. Oral. Microbiol"},{"key":"64_CR15","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1128\/IAI.06276-11","volume":"80","author":"RP Settem","year":"2012","unstructured":"Settem, R. P., El-Hassan, A. T., Honma, K., Stafford, G. P. & Sharma, A. Fusobacterium nucleatum and Tannerella forsythia induce synergistic alveolar bone loss in a mouse periodontitis model. Infect. Immun. 80, 2436\u20132443 (2012).","journal-title":"Infect. Immun."},{"key":"64_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.chom.2011.10.006","volume":"10","author":"G Hajishengallis","year":"2011","unstructured":"Hajishengallis, G. et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10, 497\u2013506 (2011).","journal-title":"Cell Host Microbe"},{"key":"64_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.chom.2013.04.005","volume":"13","author":"Y Jiao","year":"2013","unstructured":"Jiao, Y. et al. Induction of bone loss by pathobiont-mediated Nod1 signaling in the oral cavity. Cell Host Microbe 13, 595\u2013601 (2013).","journal-title":"Cell Host Microbe"},{"key":"64_CR18","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ismej.2012.174","volume":"7","author":"L Abusleme","year":"2013","unstructured":"Abusleme, L. et al. The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J. 7, 1016\u20131025 (2013).","journal-title":"ISME J."},{"key":"64_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.it.2013.09.001","volume":"35","author":"G Hajishengallis","year":"2014","unstructured":"Hajishengallis, G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol. 35, 3\u201311 (2014).","journal-title":"Trends Immunol."},{"key":"64_CR20","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1902\/jop.2008.080183","volume":"79","author":"D Graves","year":"2008","unstructured":"Graves, D. Cytokines that promote periodontal tissue destruction. J. Periodontol. 79, 1585\u20131591 (2008).","journal-title":"J. Periodontol."},{"key":"64_CR21","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.archoralbio.2015.06.018","volume":"60","author":"KN Boukortt","year":"2015","unstructured":"Boukortt, K. N. et al. Association analysis of the IL-1 gene cluster polymorphisms with aggressive and chronic periodontitis in the Algerian population. Arch. Oral. Biol. 60, 1463\u20131470 (2015).","journal-title":"Arch. Oral. Biol."},{"key":"64_CR22","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/jcpe.12279","volume":"41","author":"C Ding","year":"2014","unstructured":"Ding, C., Ji, X., Chen, X., Xu, Y. & Zhong, L. TNF\u2010\u03b1 gene promoter polymorphisms contribute to periodontitis susceptibility: evidence from 46 studies. J. Clin. Periodontol. 41, 748\u2013759 (2014).","journal-title":"J. Clin. Periodontol."},{"key":"64_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00011-013-0669-1","volume":"63","author":"ZG Li","year":"2014","unstructured":"Li, Z. G., Li, J. J., Sun, C. A., Jin, Y. & Wu, W. W. Interleukin-18 promoter polymorphisms and plasma levels are associated with increased risk of periodontitis: a meta-analysis. Inflamm. Res. 63, 45\u201352 (2014).","journal-title":"Inflamm. Res."},{"key":"64_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1620\/tjem.243.159","volume":"243","author":"K Tanaka","year":"2017","unstructured":"Tanaka, K. et al. The IL18 promoter polymorphism, rs1946518, is associated with the risk of periodontitis in Japanese women: the Kyushu Okinawa maternal and child health study. Tohoku J. Exp. Med. 243, 159\u2013164 (2017).","journal-title":"Tohoku J. Exp. Med."},{"key":"64_CR25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1399-302X.2007.00360.x","volume":"22","author":"J Alayan","year":"2007","unstructured":"Alayan, J. et al. The role of cytokines in a Porphyromonas gingivalis\u2010induced murine abscess model. Oral. Microbiol. Immunol. 22, 304\u2013312 (2007).","journal-title":"Oral. Microbiol. Immunol."},{"key":"64_CR26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ni.2260","volume":"13","author":"MA Eskan","year":"2012","unstructured":"Eskan, M. A. et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat. Immunol. 13, 465\u2013473 (2012).","journal-title":"Nat. Immunol."},{"key":"64_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1902\/jop.2000.71.4.573","volume":"71","author":"G Martuscelli","year":"2000","unstructured":"Martuscelli, G., Fiorellini, J. P., Crohin, C. C. & Howell, T. H. The effect of interleukin\u201011 on the progression of ligature\u2010induced periodontal disease in the beagle dog. J. Periodontol. 71, 573\u2013578 (2000).","journal-title":"J. Periodontol."},{"key":"64_CR28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.it.2017.08.005","volume":"39","author":"NM Moutsopoulos","year":"2018","unstructured":"Moutsopoulos, N. M. & Konkel, J. E. Tissue-specific immunity at the oral mucosal barrier. Trends Immunol. 39, 276\u2013287 (2018).","journal-title":"Trends Immunol."},{"key":"64_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/0022034518805739","volume":"98","author":"DT Graves","year":"2019","unstructured":"Graves, D. T., Corr\u00eaa, J. D. & Silva, T. A. The oral microbiota is modified by systemic diseases. J. Dent. Res. 98, 148\u2013156 (2019).","journal-title":"J. Dent. Res."},{"key":"64_CR30","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrmicro2873","volume":"10","author":"G Hajishengallis","year":"2012","unstructured":"Hajishengallis, G., Darveau, R. P. & Curtis, M. A. The keystone-pathogen hypothesis. Nat. Rev. Microbiol. 10, 717\u2013725 (2012).","journal-title":"Nat. Rev. Microbiol."},{"key":"64_CR31","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/154405910808700908","volume":"87","author":"SL Gaffen","year":"2008","unstructured":"Gaffen, S. L. & Hajishengallis, G. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1\/Th2 paradigm in the context of Th17 cells and IL-17. J. Dent. Res. 87, 817\u2013828 (2008).","journal-title":"J. Dent. Res."},{"key":"64_CR32","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","volume":"50","author":"A Mantovani","year":"2019","unstructured":"Mantovani, A., Dinarello, C. A., Molgora, M. & Garlanda, C. Interleukin-1 and related cytokines in the regulation of inflammation and immunity. Immunity 50, 778\u2013795 (2019).","journal-title":"Immunity"},{"key":"64_CR33","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","volume":"27","author":"CA Dinarello","year":"2009","unstructured":"Dinarello, C. A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519\u2013550 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"64_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","volume":"281","author":"CA Dinarello","year":"2018","unstructured":"Dinarello, C. A. Overview of the IL\u20101 family in innate inflammation and acquired immunity. Immunol. Rev. 281, 8\u201327 (2018).","journal-title":"Immunol. Rev."},{"key":"64_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1089\/gtmb.2014.0275","volume":"19","author":"V Lavu","year":"2015","unstructured":"Lavu, V. et al. Polymorphic regions in the interleukin-1 gene and susceptibility to chronic periodontitis: a genetic association study. Genet. Test. Mol. Biomark. 19, 175\u2013181 (2015).","journal-title":"Genet. Test. Mol. Biomark."},{"key":"64_CR36","doi-asserted-by":"publisher","first-page":"7119","DOI":"10.1073\/pnas.0902745106","volume":"106","author":"SZ Ben-Sasson","year":"2009","unstructured":"Ben-Sasson, S. Z. et al. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc. Natl Acad. Sci. USA 106, 7119\u20137124 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"64_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233\u2013240 (2005).","journal-title":"J. Exp. Med."},{"key":"64_CR38","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1189\/jlb.1012543","volume":"93","author":"KH Mills","year":"2013","unstructured":"Mills, K. H., Dungan, L. S., Jones, S. A. & Harris, J. The role of inflammasome\u2010derived IL\u20101 in driving IL\u201017 responses. J. Leukoc. Biol. 93, 489\u2013497 (2013).","journal-title":"J. Leukoc. Biol."},{"key":"64_CR39","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.archoralbio.2014.04.007","volume":"59","author":"L Gilowski","year":"2014","unstructured":"Gilowski, L., Wiench, R., P\u0142ocica, I. & Krzemi\u0144ski, T. F. Amount of interleukin-1\u03b2 and interleukin-1 receptor antagonist in periodontitis and healthy patients. Arch. Oral. Biol. 59, 729\u2013734 (2014).","journal-title":"Arch. Oral. Biol."},{"key":"64_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3892\/etm.2014.1724","volume":"8","author":"C Reis","year":"2014","unstructured":"Reis, C. et al. Clinical improvement following therapy for periodontitis: association with a decrease in IL1 and IL6. Exp. Ther. Med. 8, 323\u2013327 (2014).","journal-title":"Exp. Ther. Med."},{"key":"64_CR41","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/odi.13003","volume":"25","author":"AL Garc\u00eda\u2010Hern\u00e1ndez","year":"2019","unstructured":"Garc\u00eda\u2010Hern\u00e1ndez, A. L. et al. Upregulation of proteins of the NLRP3 inflammasome in patients with periodontitis and uncontrolled type 2 diabetes. Oral. Dis. 25, 596\u2013608 (2019).","journal-title":"Oral. Dis."},{"key":"64_CR42","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1902\/jop.2017.170244","volume":"88","author":"DM Isaza\u2010Guzm\u00e1n","year":"2017","unstructured":"Isaza\u2010Guzm\u00e1n, D. M., Medina\u2010Piedrah\u00edta, V. M., Guti\u00e9rrez\u2010Henao, C. & Tob\u00f3n\u2010Arroyave, S. I. Salivary levels of NLRP3 inflammasome\u2010related proteins as potential biomarkers of periodontal clinical status. J. Periodontol. 88, 1329\u20131338 (2017).","journal-title":"J. Periodontol."},{"key":"64_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168080","volume":"11","author":"O Lap\u00e9rine","year":"2016","unstructured":"Lap\u00e9rine, O. et al. Interleukin-33 and RANK-L interplay in the alveolar bone loss associated to periodontitis. PLoS ONE 11, e0168080 (2016).","journal-title":"PLoS ONE"},{"key":"64_CR44","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/jre.12241","volume":"50","author":"M Sa\u011flam","year":"2015","unstructured":"Sa\u011flam, M. et al. Levels of interleukin\u201037 in gingival crevicular fluid, saliva, or plasma in periodontal disease. J. Periodontal Res. 50, 614\u2013621 (2015).","journal-title":"J. Periodontal Res."},{"key":"64_CR45","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1902\/jop.2011.110239","volume":"83","author":"N Buduneli","year":"2012","unstructured":"Buduneli, N., \u00d6z\u00e7aka, \u00d6. & Nalbantsoy, A. Interleukin\u201033 levels in gingival crevicular fluid, saliva, or plasma do not differentiate chronic periodontitis. J. Periodontol. 83, 362\u2013368 (2012).","journal-title":"J. Periodontol."},{"key":"64_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.archoralbio.2014.08.021","volume":"60","author":"SF Kur\u015funlu","year":"2015","unstructured":"Kur\u015funlu, S. F., \u00d6zt\u00fcrk, V. \u00d6., Han, B., Atmaca, H. & Emingil, G. Gingival crevicular fluid interleukin-36\u03b2 (-1F8), interleukin-36\u03b3 (-1F9) and interleukin-33 (-1F11) levels in different periodontal disease. Arch. Oral. Biol. 60, 77\u201383 (2015).","journal-title":"Arch. Oral. Biol."},{"key":"64_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/jre.12078","volume":"49","author":"E Papathanasiou","year":"2014","unstructured":"Papathanasiou, E. et al. Gingival crevicular fluid levels of interferon\u2010\u03b3, but not interleukin\u20104 or\u201033 or thymic stromal lymphopoietin, are increased in inflamed sites in patients with periodontal disease. J. Periodontal Res. 49, 55\u201361 (2014).","journal-title":"J. Periodontal Res."},{"key":"64_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152794","volume":"11","author":"H Tada","year":"2016","unstructured":"Tada, H. et al. Porphyromonas gingivalis gingipain-dependently enhances IL-33 production in human gingival epithelial cells. PLoS ONE 11, e0152794 (2016).","journal-title":"PLoS ONE"},{"key":"64_CR49","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2220\/biomedres.38.189","volume":"38","author":"H Tada","year":"2017","unstructured":"Tada, H. et al. Increases in IL-33 production by fimbriae and lipopeptide from Porphyromonas gingivalis in mouse bone marrow-derived dendritic cells via toll-like receptor 2. Biomed. Res. 38, 189\u2013195 (2017).","journal-title":"Biomed. Res."},{"key":"64_CR50","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/jre.12235","volume":"50","author":"S K\u00f6seo\u011flu","year":"2015","unstructured":"K\u00f6seo\u011flu, S., Hatipo\u011flu, M., Sa\u011flam, M., Enho\u015f, \u015e. & Esen, H. H. Interleukin\u201033 could play an important role in the pathogenesis of periodontitis. J. Periodontal Res. 50, 525\u2013534 (2015).","journal-title":"J. Periodontal Res."},{"key":"64_CR51","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1177\/0022034515577815","volume":"94","author":"J Malcolm","year":"2015","unstructured":"Malcolm, J. et al. IL-33 exacerbates periodontal disease through induction of RANKL. J. Dent. Res. 94, 968\u2013975 (2015).","journal-title":"J. Dent. Res."},{"key":"64_CR52","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/378088a0","volume":"378","author":"H Okamura","year":"1995","unstructured":"Okamura, H. et al. Cloning of a new cytokine that induces IFN-\u03b3 production by T cells. Nature 378, 88\u201391 (1995).","journal-title":"Nature"},{"key":"64_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1399-302X.2007.00408.x","volume":"23","author":"CM Figueredo","year":"2008","unstructured":"Figueredo, C. M. et al. Increased interleukin\u201018 in gingival crevicular fluid from periodontitis patients. Oral. Microbiol. Immunol. 23, 173\u2013176 (2008).","journal-title":"Oral. Microbiol. Immunol."},{"key":"64_CR54","first-page":"592","volume":"46","author":"\u00d6 \u00d6z\u00e7aka","year":"2011","unstructured":"\u00d6z\u00e7aka, \u00d6., Nalbantsoy, A. & Buduneli, N. Interleukin\u201017 and interleukin\u201018 levels in saliva and plasma of patients with chronic periodontitis. J. Periodontal Res. 46, 592\u2013598 (2011).","journal-title":"J. Periodontal Res."},{"key":"64_CR55","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1601-0825.2011.01798.x","volume":"17","author":"P S\u00e1nchez\u2010Hern\u00e1ndez","year":"2011","unstructured":"S\u00e1nchez\u2010Hern\u00e1ndez, P. et al. IL\u201012 and IL\u201018 levels in serum and gingival tissue in aggressive and chronic periodontitis. Oral. Dis. 17, 522\u2013529 (2011).","journal-title":"Oral. Dis."},{"key":"64_CR56","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1590\/S0103-64402012000400020","volume":"23","author":"BO Campos","year":"2012","unstructured":"Campos, B. O., Fischer, R. G., Gustafsson, A. & Figueredo, C. M. Effectiveness of non-surgical treatment to reduce IL-18 levels in the gingival crevicular fluid of patients with periodontal disease. Braz. Dent. J. 23, 428\u2013432 (2012).","journal-title":"Braz. Dent. J."},{"key":"64_CR57","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2334\/josnusd.51.261","volume":"51","author":"AR Pradeep","year":"2009","unstructured":"Pradeep, A. R., Hadge, P., Chowdhry, S., Patel, S. & Happy, D. Exploring the role of Th1 cytokines: interleukin-17 and interleukin-18 in periodontal health and disease. J. Oral. Sci. 51, 261\u2013266 (2009).","journal-title":"J. Oral. Sci."},{"key":"64_CR58","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4103\/0972-124X.183098","volume":"20","author":"V Nair","year":"2016","unstructured":"Nair, V., Bandyopadhyay, P., Kundu, D. & Das, S. Estimation of interleukin-18 in the gingival crevicular fluid and serum of Bengali population with periodontal health and disease. J. Indian Soc. Periodontol. 20, 260\u2013264 (2016).","journal-title":"J. Indian Soc. Periodontol."},{"key":"64_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cyto.2008.11.005","volume":"45","author":"M Hamedi","year":"2009","unstructured":"Hamedi, M. et al. Porphyromonas gingivalis culture supernatants differentially regulate Interleukin-1\u03b2 and Interleukin-18 in human monocytic cells. Cytokine 45, 99\u2013104 (2009).","journal-title":"Cytokine"},{"key":"64_CR60","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.micinf.2012.03.002","volume":"14","author":"M Yee","year":"2012","unstructured":"Yee, M., Kim, A., Alpagot, T., D\u00fczg\u00fcne\u015f, N. & Konopka, K. Porphyromonas gingivalis stimulates IL-18 secretion in human monocytic THP-1 cells. Microbes Infect. 14, 684\u2013689 (2012).","journal-title":"Microbes Infect."},{"key":"64_CR61","first-page":"703","volume":"19","author":"F Wang","year":"2019","unstructured":"Wang, F., Guan, M., Wei, L. & Yan, H. IL18 promotes the secretion of matrix metalloproteinases in human periodontal ligament fibroblasts by activating NF\u03baB signaling. Mol. Med. Rep. 19, 703\u2013710 (2019).","journal-title":"Mol. Med. Rep."},{"key":"64_CR62","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1620\/tjem.232.215","volume":"232","author":"K Yoshinaka","year":"2014","unstructured":"Yoshinaka, K. et al. Increased interleukin-18 in the gingival tissues evokes chronic periodontitis after bacterial infection. Tohoku J. Exp. Med. 232, 215\u2013222 (2014).","journal-title":"Tohoku J. Exp. Med."},{"key":"64_CR63","unstructured":"Sehgal, P. B., Grieninger, G. & Tosato, G. Regulation of the Acute Phase and Immune Responses (The New York Academy of Sciences, 1989)."},{"key":"64_CR64","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3389\/fimmu.2016.00479","volume":"7","author":"H Hasegawa","year":"2016","unstructured":"Hasegawa, H. et al. Expanding diversity in molecular structures and functions of the IL-6\/IL-12 heterodimeric cytokine family. Front. Immunol. 7, 479 (2016).","journal-title":"Front. Immunol."},{"key":"64_CR65","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coi.2018.09.002","volume":"55","author":"BE Jones","year":"2018","unstructured":"Jones, B. E., Maerz, M. D. & Buckner, J. H. IL-6: a cytokine at the crossroads of autoimmunity. Curr. Opin. Immunol. 55, 9\u201314 (2018).","journal-title":"Curr. Opin. Immunol."},{"key":"64_CR66","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2019.03.027","volume":"50","author":"M Murakami","year":"2019","unstructured":"Murakami, M., Kamimura, D. & Hirano, T. Pleiotropy and specificity: insights from the interleukin 6 family of cytokines. Immunity 50, 812\u2013831 (2019).","journal-title":"Immunity"},{"key":"64_CR67","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/ni.2227","volume":"13","author":"LW Collison","year":"2012","unstructured":"Collison, L. W. et al. The composition and signaling of the IL-35 receptor are unconventional. Nat. Immunol. 13, 290\u2013299 (2012).","journal-title":"Nat. Immunol."},{"key":"64_CR68","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","volume":"50","author":"S Kang","year":"2019","unstructured":"Kang, S., Tanaka, T., Narazaki, M. & Kishimoto, T. Targeting interleukin-6 signaling in clinic. Immunity 50, 1007\u20131023 (2019).","journal-title":"Immunity"},{"key":"64_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2000080","volume":"15","author":"S Riethmueller","year":"2017","unstructured":"Riethmueller, S. et al. Proteolytic origin of the soluble human IL-6R in vivo and a decisive role of N-glycosylation. PLoS Biol. 15, e2000080 (2017).","journal-title":"PLoS Biol."},{"key":"64_CR70","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1126\/science.1411569","volume":"258","author":"T Kishimoto","year":"1992","unstructured":"Kishimoto, T., Akira, S. & Taga, T. Interleukin-6 and its receptor: a paradigm for cytokines. Science 258, 593\u2013597 (1992).","journal-title":"Science"},{"key":"64_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20030407","volume":"374","author":"PC Heinrich","year":"2003","unstructured":"Heinrich, P. C. et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374, 1\u201320 (2003).","journal-title":"Biochem. J."},{"key":"64_CR72","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/43219","volume":"387","author":"T Naka","year":"1997","unstructured":"Naka, T. et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924\u2013929 (1997).","journal-title":"Nature"},{"key":"64_CR73","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1128\/MCB.18.7.4109","volume":"18","author":"M Takahashi-Tezuka","year":"1998","unstructured":"Takahashi-Tezuka, M. et al. Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Mol. Cell. Biol. 18, 4109\u20134117 (1998).","journal-title":"Mol. Cell. Biol."},{"key":"64_CR74","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cyto.2014.05.024","volume":"70","author":"J Wolf","year":"2014","unstructured":"Wolf, J., Rose-John, S. & Garbers, C. Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine 70, 11\u201320 (2014).","journal-title":"Cytokine"},{"key":"64_CR75","doi-asserted-by":"publisher","first-page":"ra88","DOI":"10.1126\/scisignal.aaa5157","volume":"8","author":"WW Lin","year":"2015","unstructured":"Lin, W. W. et al. The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development. Sci. Signal. 8, ra88 (2015).","journal-title":"Sci. Signal."},{"key":"64_CR76","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.4049\/jimmunol.0901528","volume":"184","author":"GW Jones","year":"2010","unstructured":"Jones, G. W. et al. Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells. J. Immunol. 184, 2130\u20132139 (2010).","journal-title":"J. Immunol."},{"key":"64_CR77","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ni.3632","volume":"18","author":"S Heink","year":"2017","unstructured":"Heink, S. et al. Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells. Nat. Immunol. 18, 74\u201385 (2017).","journal-title":"Nat. Immunol."},{"key":"64_CR78","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1767","volume":"10","author":"T Duhen","year":"2009","unstructured":"Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A. & Sallusto, F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10, 857\u2013863 (2009).","journal-title":"Nat. Immunol."},{"key":"64_CR79","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector T H 17 and regulatory T cells. Nature 441, 235\u2013238 (2006).","journal-title":"Nature"},{"key":"64_CR80","first-page":"9612421","volume":"2016","author":"J Zhu","year":"2016","unstructured":"Zhu, J. et al. Interleukin-6-174G\/C polymorphism contributes to periodontitis susceptibility: an updated meta-analysis of 21 case-control studies. Dis. Markers 2016, 9612421 (2016).","journal-title":"Dis. Markers"},{"key":"64_CR81","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/jcpe.12557","volume":"43","author":"AF Stadler","year":"2016","unstructured":"Stadler, A. F. et al. Gingival crevicular fluid levels of cytokines\/chemokines in chronic periodontitis: a meta\u2010analysis. J. Clin. Periodontol. 43, 727\u2013745 (2016).","journal-title":"J. Clin. Periodontol."},{"key":"64_CR82","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/jcpe.12286","volume":"41","author":"JL Ebersole","year":"2014","unstructured":"Ebersole, J. L. et al. Cytokine gene expression profiles during initiation, progression and resolution of periodontitis. J. Clin. Periodontol. 41, 853\u2013861 (2014).","journal-title":"J. Clin. Periodontol."},{"key":"64_CR83","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1002\/art.22175","volume":"54","author":"F De Benedetti","year":"2006","unstructured":"De Benedetti, F. et al. Impaired skeletal development in interleukin\u20106\u2013transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum. 54, 3551\u20133563 (2006).","journal-title":"Arthritis Rheum."},{"key":"64_CR84","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1159\/000465455","volume":"41","author":"Q Wu","year":"2017","unstructured":"Wu, Q., Zhou, X., Huang, D., Yingchen, J. & Kang, F. IL-6 enhances osteocyte-mediated osteoclastogenesis by promoting JAK2 and RANKL activity in vitro. Cell. Physiol. Biochem. 41, 1360\u20131369 (2017).","journal-title":"Cell. Physiol. Biochem."},{"key":"64_CR85","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/jcpe.13065","volume":"46","author":"W Pan","year":"2019","unstructured":"Pan, W. et al. Traumatic occlusion aggravates bone loss during periodontitis and activates Hippo\u2010YAP pathway. J. Clin. Periodontol. 46, 438\u2013447 (2019).","journal-title":"J. Clin. Periodontol."},{"key":"64_CR86","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/jcpe.13060","volume":"46","author":"W Pan","year":"2019","unstructured":"Pan, W. et al. Inhibition of Ctsk alleviates periodontitis and comorbid rheumatoid arthritis via downregulation of the TLR9 signalling pathway. J. Clin. Periodontol. 46, 286\u2013296 (2019).","journal-title":"J. Clin. Periodontol."},{"key":"64_CR87","first-page":"1","volume":"1","author":"EKN Santos\u2010Lima","year":"2019","unstructured":"Santos\u2010Lima, E. K. N. et al. Production of interferon gamma, interleukin 6 and interleukin 1\u03b2 by human peripheral blood mononuclear cells stimulated with novel Lys\u2010gingipain synthetic peptides. J. Periodontol. 1, 1\u201312 (2019).","journal-title":"J. Periodontol."},{"key":"64_CR88","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/odi.12983","volume":"25","author":"LN Zhou","year":"2019","unstructured":"Zhou, L. N. et al. Macrophage polarization in human gingival tissue in response to periodontal disease. Oral. Dis. 25, 265\u2013273 (2019).","journal-title":"Oral. Dis."},{"key":"64_CR89","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/cre2.162","volume":"24","author":"A Zekeridou","year":"2019","unstructured":"Zekeridou, A., Mombelli, A., Cancela, J., Courvoisier, D. & Giannopoulou, C. Systemic inflammatory burden and local inflammation in periodontitis: what is the link between inflammatory biomarkers in serum and gingival crevicular fluid? Clin. Exp. Dent. Res. 24, 128\u2013135 (2019).","journal-title":"Clin. Exp. Dent. Res"},{"key":"64_CR90","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","volume":"72","author":"EA Carswell","year":"1975","unstructured":"Carswell, E. A. et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl Acad. Sci. USA 72, 3666\u20133670 (1975).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"64_CR91","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/S0021-9258(18)89559-X","volume":"260","author":"BB Aggarwal","year":"1985","unstructured":"Aggarwal, B. B., Henzel, W. J., Moffat, B., Kohr, W. J. & Harkins, R. N. Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line. J. Biol. Chem. 260, 2334\u20132344 (1985).","journal-title":"J. Biol. Chem."},{"key":"64_CR92","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/S0021-9258(18)89560-6","volume":"260","author":"BB Aggarwal","year":"1985","unstructured":"Aggarwal, B. B. et al. Human tumor necrosis factor. Production, purification, and characterization. J. Biol. Chem. 260, 2345\u20132354 (1985).","journal-title":"J. Biol. Chem."},{"key":"64_CR93","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0021-9258(17)43716-1","volume":"259","author":"BB Aggarwal","year":"1984","unstructured":"Aggarwal, B. B., Moffat, B. & Harkins, R. N. Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization. J. Biol. Chem. 259, 686\u2013691 (1984).","journal-title":"J. Biol. Chem."},{"key":"64_CR94","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nri3834","volume":"15","author":"D Brenner","year":"2015","unstructured":"Brenner, D., Blaser, H. & Mak, T. W. Regulation of tumour necrosis factor signalling: live or let die. Nat. Rev. Immunol. 15, 362\u2013374 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"64_CR95","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0092-8674(88)90486-2","volume":"53","author":"M Kriegler","year":"1988","unstructured":"Kriegler, M., Perez, C., DeFay, K., Albert, I. & Lu, S. A novel form of TNF\/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53, 45\u201353 (1988).","journal-title":"Cell"},{"key":"64_CR96","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/385729a0","volume":"385","author":"RA Black","year":"1997","unstructured":"Black, R. A. et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-\u03b1 from cells. Nature 385, 729\u2013733 (1997).","journal-title":"Nature"},{"key":"64_CR97","doi-asserted-by":"crossref","first-page":"17595","DOI":"10.1016\/S0021-9258(18)71533-0","volume":"264","author":"MJ Eck","year":"1989","unstructured":"Eck, M. J. & Sprang, S. R. The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding. J. Biol. Chem. 264, 17595\u201317605 (1989).","journal-title":"J. Biol. Chem."},{"key":"64_CR98","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/338225a0","volume":"338","author":"EY Jones","year":"1989","unstructured":"Jones, E. Y., Stuart, D. I. & Walker, N. P. C. Structure of tumour necrosis factor. Nature 338, 225\u2013228 (1989).","journal-title":"Nature"},{"key":"64_CR99","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nrd3030","volume":"9","author":"D Faustman","year":"2010","unstructured":"Faustman, D. & Davis, M. TNF receptor 2 pathway: drug target for autoimmune diseases. Nat. Rev. Drug Discov. 9, 482\u2013493 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"64_CR100","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0092-8674(95)90070-5","volume":"81","author":"H Hsu","year":"1995","unstructured":"Hsu, H., Xiong, J. & Goeddel, D. V. The TNF receptor 1-associated protein TRADD signals cell death and NF-\u03baB activation. Cell 81, 495\u2013504 (1995).","journal-title":"Cell"},{"key":"64_CR101","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1074-7613(00)80252-6","volume":"4","author":"H Hsu","year":"1996","unstructured":"Hsu, H., Huang, J., Shu, H.-B., Baichwal, V. & Goeddel, D. V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387\u2013396 (1996).","journal-title":"Immunity"},{"key":"64_CR102","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.molcel.2006.03.026","volume":"22","author":"C-K Ea","year":"2006","unstructured":"Ea, C.-K., Deng, L., Xia, Z.-P., Pineda, G. & Chen, Z. J. Activation of IKK by TNF\u03b1 requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22, 245\u2013257 (2006).","journal-title":"Mol. Cell"},{"key":"64_CR103","doi-asserted-by":"publisher","first-page":"13636","DOI":"10.1074\/jbc.M600620200","volume":"281","author":"H Li","year":"2006","unstructured":"Li, H., Kobayashi, M., Blonska, M., You, Y. & Lin, X. Ubiquitination of RIP is required for tumor necrosis factor \u03b1-induced NF-\u03baB activation. J. Biol. Chem. 281, 13636\u201313643 (2006).","journal-title":"J. Biol. Chem."},{"key":"64_CR104","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cyto.2016.08.027","volume":"101","author":"W-Y Tseng","year":"2018","unstructured":"Tseng, W.-Y. et al. TNFR signalling and its clinical implications. Cytokine 101, 19\u201325 (2018).","journal-title":"Cytokine"},{"key":"64_CR105","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.molcel.2009.10.013","volume":"36","author":"TL Haas","year":"2009","unstructured":"Haas, T. L. et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831\u2013844 (2009).","journal-title":"Mol. Cell"},{"key":"64_CR106","doi-asserted-by":"publisher","first-page":"a000158","DOI":"10.1101\/cshperspect.a000158","volume":"2","author":"A Isra\u00ebl","year":"2010","unstructured":"Isra\u00ebl, A. The IKK complex, a central regulator of NF-\u03baB activation. Cold Spring Harb. Perspect. Biol. 2, a000158 (2010).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"64_CR107","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.0105-2896.2006.00375.x","volume":"210","author":"A Hoffmann","year":"2006","unstructured":"Hoffmann, A. & Baltimore, D. Circuitry of nuclear factor \u03baB signaling. Immunol. Rev. 210, 171\u2013186 (2006).","journal-title":"Immunol. Rev."},{"key":"64_CR108","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/35085597","volume":"412","author":"C Wang","year":"2001","unstructured":"Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346\u2013351 (2001).","journal-title":"Nature"},{"key":"64_CR109","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2004.08.008","volume":"15","author":"A Kanayama","year":"2004","unstructured":"Kanayama, A. et al. TAB2 and TAB3 activate the NF-\u03baB pathway through binding to polyubiquitin chains. Mol. Cell 15, 535\u2013548 (2004).","journal-title":"Mol. Cell"},{"key":"64_CR110","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1101\/gad.1360605","volume":"19","author":"J-H Shim","year":"2005","unstructured":"Shim, J.-H. et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19, 2668\u20132681 (2005).","journal-title":"Genes Dev."},{"key":"64_CR111","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","volume":"114","author":"O Micheau","year":"2003","unstructured":"Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181\u2013190 (2003).","journal-title":"Cell"},{"key":"64_CR112","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2008.03.036","volume":"133","author":"L Wang","year":"2008","unstructured":"Wang, L., Du, F. & Wang, X. TNF-\u03b1 induces two distinct caspase-8 activation pathways. Cell 133, 693\u2013703 (2008).","journal-title":"Cell"},{"key":"64_CR113","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.4049\/jimmunol.179.4.2359","volume":"179","author":"G Hajishengallis","year":"2007","unstructured":"Hajishengallis, G., Shakhatreh, M.-A. K., Wang, M. & Liang, S. Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo. J. Immunol. 179, 2359\u20132367 (2007).","journal-title":"J. Immunol."},{"key":"64_CR114","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213\u2013227 (2012).","journal-title":"Cell"},{"key":"64_CR115","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","volume":"39","author":"JM Murphy","year":"2013","unstructured":"Murphy, J. M. et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39, 443\u2013453 (2013).","journal-title":"Immunity"},{"key":"64_CR116","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1084\/jem.191.2.275","volume":"191","author":"K Kobayashi","year":"2000","unstructured":"Kobayashi, K. et al. Tumor necrosis factor \u03b1 stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL\u2013RANK interaction. J. Exp. Med. 191, 275\u2013286 (2000).","journal-title":"J. Exp. Med."},{"key":"64_CR117","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/ar1857","volume":"8","author":"SL Teitelbaum","year":"2005","unstructured":"Teitelbaum, S. L. Osteoclasts: culprits in inflammatory osteolysis. Arthritis Res. Ther. 8, 201 (2005).","journal-title":"Arthritis Res. Ther."},{"key":"64_CR118","doi-asserted-by":"publisher","first-page":"181849","DOI":"10.1155\/2013\/181849","volume":"2013","author":"H Kitaura","year":"2013","unstructured":"Kitaura, H. et al. Immunological reaction in TNF-\u03b1-mediated osteoclast formation and bone resorption in vitro and in vivo. Clin. Dev. Immunol. 2013, 181849 (2013).","journal-title":"Clin. Dev. Immunol."},{"key":"64_CR119","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fimmu.2014.00511","volume":"5","author":"MC Walsh","year":"2014","unstructured":"Walsh, M. C. & Choi, Y. Biology of the RANKL\u2013RANK\u2013OPG system in immunity, bone, and beyond. Front. Immunol. 5, 511 (2014).","journal-title":"Front. Immunol."},{"key":"64_CR120","first-page":"48","volume":"5","author":"B Osta","year":"2014","unstructured":"Osta, B., Benedetti, G. & Miossec, P. Classical and paradoxical effects of TNF-\u03b1 on bone homeostasis. Front. Immunol. 5, 48 (2014).","journal-title":"Front. Immunol."},{"key":"64_CR121","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/jre.12339","volume":"51","author":"K Algate","year":"2016","unstructured":"Algate, K., Haynes, D., Bartold, P., Crotti, T. & Cantley, M. The effects of tumour necrosis factor\u2010\u03b1 on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes. J. Periodontal Res. 51, 549\u2013566 (2016).","journal-title":"J. Periodontal Res."},{"key":"64_CR122","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jebdp.2018.04.001","volume":"18","author":"DF Madureira","year":"2018","unstructured":"Madureira, D. F. et al. Tumor necrosis factor-alpha in gingival crevicular fluid as a diagnostic marker for periodontal diseases: a systematic review. J. Evid. Based Dent. Pract. 18, 315\u2013331 (2018).","journal-title":"J. Evid. Based Dent. Pract."},{"key":"64_CR123","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1046\/j.0303-6979.2003.00425.x","volume":"30","author":"R G\u00f3rska","year":"2003","unstructured":"G\u00f3rska, R. et al. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J. Clin. Periodontol. 30, 1046\u20131052 (2003).","journal-title":"J. Clin. Periodontol."},{"key":"64_CR124","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/jre.12131","volume":"49","author":"R Fujihara","year":"2014","unstructured":"Fujihara, R. et al. Tumor necrosis factor\u2010\u03b1 enhances RANKL expression in gingival epithelial cells via protein kinase A signaling. J. Periodontal Res. 49, 508\u2013517 (2014).","journal-title":"J. Periodontal Res."},{"key":"64_CR125","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2353\/ajpath.2006.060180","volume":"169","author":"T Kawai","year":"2006","unstructured":"Kawai, T. et al. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am. J. Pathol. 169, 987\u2013998 (2006).","journal-title":"Am. J. Pathol."},{"key":"64_CR126","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1902\/jop.2016.150713","volume":"87","author":"FG Basso","year":"2016","unstructured":"Basso, F. G. et al. Tumor necrosis factor\u2010\u03b1 and interleukin (IL)\u20101\u03b2, IL\u20106, and IL\u20108 impair in vitro migration and induce apoptosis of gingival fibroblasts and epithelial cells, delaying wound healing. J. Periodontol. 87, 990\u2013996 (2016).","journal-title":"J. Periodontol."},{"key":"64_CR127","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1902\/jop.2012.120225","volume":"84","author":"R Arancibia","year":"2013","unstructured":"Arancibia, R. et al. Tumor necrosis factor\u2010\u03b1 inhibits transforming growth factor\u2010\u03b2\u2013stimulated myofibroblastic differentiation and extracellular matrix production in human gingival fibroblasts. J. Periodontol. 84, 683\u2013693 (2013).","journal-title":"J. Periodontol."},{"key":"64_CR128","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/jcpe.12803","volume":"45","author":"D Polak","year":"2018","unstructured":"Polak, D. & Shapira, L. An update on the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J. Clin. Periodontol. 45, 150\u2013166 (2018).","journal-title":"J. Clin. Periodontol."},{"key":"64_CR129","doi-asserted-by":"publisher","first-page":"6034546","DOI":"10.1155\/2019\/6034546","volume":"2019","author":"F Ceccarelli","year":"2019","unstructured":"Ceccarelli, F. et al. Periodontitis and rheumatoid arthritis: the same inflammatory mediators? Mediat. Inflamm. 2019, 6034546 (2019).","journal-title":"Mediat. Inflamm."},{"key":"64_CR130","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","volume":"50","author":"EDT Wojno","year":"2019","unstructured":"Wojno, E. D. T., Hunter, C. A. & Stumhofer, J. S. The immunobiology of the interleukin-12 family: room for discovery. Immunity 50, 851\u2013870 (2019).","journal-title":"Immunity"},{"key":"64_CR131","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","volume":"13","author":"B Oppmann","year":"2000","unstructured":"Oppmann, B. et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715\u2013725 (2000).","journal-title":"Immunity"},{"key":"64_CR132","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0960-9822(93)90009-D","volume":"3","author":"JF Bazan","year":"1993","unstructured":"Bazan, J. F. Emerging families of cytokines and receptors. Curr. Biol. 3, 603\u2013606 (1993).","journal-title":"Curr. Biol."},{"key":"64_CR133","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1091\/mbc.E14-12-1645","volume":"27","author":"DM Floss","year":"2016","unstructured":"Floss, D. M. et al. Defining the functional binding sites of interleukin 12 receptor \u03b21 and interleukin 23 receptor to Janus kinases. Mol. Biol. Cell 27, 2301\u20132316 (2016).","journal-title":"Mol. Biol. Cell"},{"key":"64_CR134","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","volume":"3","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133\u2013146 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"64_CR135","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni0507-448","volume":"8","author":"LH Glimcher","year":"2007","unstructured":"Glimcher, L. H. Trawling for treasure: tales of T-bet. Nat. Immunol. 8, 448\u2013450 (2007).","journal-title":"Nat. Immunol."},{"key":"64_CR136","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S1074-7613(03)00296-6","volume":"19","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri, G., Pflanz, S. & Kastelein, R. A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19, 641\u2013644 (2003).","journal-title":"Immunity"},{"key":"64_CR137","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1046\/j.0303-6979.2003.00435.x","volume":"30","author":"SJ Fokkema","year":"2003","unstructured":"Fokkema, S. J. et al. Increased release of IL\u201012p70 by monocytes after periodontal therapy. J. Clin. Periodontol. 30, 1091\u20131096 (2003).","journal-title":"J. Clin. Periodontol."},{"key":"64_CR138","first-page":"ZC90","volume":"8","author":"A Sharma","year":"2014","unstructured":"Sharma, A., Khattak, B., Naagtilak, S., Singh, G. & Bano, T. Effect of periodontal therapy on salivary interleukin-12 levels in chronic periodontitis. J. Clin. Diagn. Res. 8, ZC90\u2013ZC92 (2014).","journal-title":"J. Clin. Diagn. Res."},{"key":"64_CR139","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1902\/jop.2005.76.5.785","volume":"76","author":"R Johnson","year":"2005","unstructured":"Johnson, R. & Serio, F. Interleukin\u201018 concentrations and the pathogenesis of periodontal disease. J. Periodontol. 76, 785\u2013790 (2005).","journal-title":"J. Periodontol."},{"key":"64_CR140","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.4049\/jimmunol.136.7.2478","volume":"136","author":"M Gowen","year":"1986","unstructured":"Gowen, M. & Mundy, G. R. Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro. J. Immunol. 136, 2478\u20132482 (1986).","journal-title":"J. Immunol."},{"key":"64_CR141","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.4049\/jimmunol.166.8.4915","volume":"166","author":"NJ Horwood","year":"2001","unstructured":"Horwood, N. J., Elliott, J., Martin, T. J. & Gillespie, M. T. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J. Immunol. 166, 4915\u20134921 (2001).","journal-title":"J. Immunol."},{"key":"64_CR142","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/CDLI.11.1.106-110.2004","volume":"11","author":"H Sasaki","year":"2004","unstructured":"Sasaki, H. et al. Gamma interferon (IFN-\u03b3) and IFN-\u03b3-inducing cytokines interleukin-12 (IL-12) and IL-18 do not augment infection-stimulated bone resorption in vivo. Clin. Diagn. Lab. Immunol. 11, 106\u2013110 (2004).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"64_CR143","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2019.03.028","volume":"50","author":"WJ Leonard","year":"2019","unstructured":"Leonard, W. J., Lin, J.-X. & O\u2019Shea, J. J. The \u03b3c family of cytokines: basic biology to therapeutic ramifications. Immunity 50, 832\u2013850 (2019).","journal-title":"Immunity"},{"key":"64_CR144","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1073\/pnas.87.18.6934","volume":"87","author":"JF Bazan","year":"1990","unstructured":"Bazan, J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl Acad. Sci. USA 87, 6934\u20136938 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"64_CR145","doi-asserted-by":"publisher","first-page":"6642","DOI":"10.1074\/jbc.M513118200","volume":"281","author":"I Lorenzen","year":"2006","unstructured":"Lorenzen, I., Dingley, A. J., Jacques, Y. & Gr\u00f6tzinger, J. The structure of the interleukin-15\u03b1 receptor and its implications for ligand binding. J. Biol. Chem. 281, 6642\u20136647 (2006).","journal-title":"J. Biol. Chem."},{"key":"64_CR146","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1126\/science.1109745","volume":"308","author":"M Rickert","year":"2005","unstructured":"Rickert, M., Wang, X., Boulanger, M. J., Goriatcheva, N. & Garcia, K. C. The structure of interleukin-2 complexed with its alpha receptor. Science 308, 1477\u20131480 (2005).","journal-title":"Science"},{"key":"64_CR147","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1084\/jem.172.3.921","volume":"172","author":"G Le Gros","year":"1990","unstructured":"Le Gros, G., Ben-Sasson, S. Z., Seder, R., Finkelman, F. & Paul, W. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172, 921\u2013929 (1990).","journal-title":"J. Exp. Med."},{"key":"64_CR148","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1084\/jem.162.5.1726","volume":"162","author":"ES Vitetta","year":"1985","unstructured":"Vitetta, E. S. et al. Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1. J. Exp. Med. 162, 1726\u20131731 (1985).","journal-title":"J. Exp. Med."},{"key":"64_CR149","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/prd.12002","volume":"64","author":"A Cekici","year":"2014","unstructured":"Cekici, A., Kantarci, A., Hasturk, H. & Van Dyke, T. E. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000 64, 57\u201380 (2014).","journal-title":"Periodontol 2000"},{"key":"64_CR150","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1177\/0022034510376402","volume":"89","author":"GP Garlet","year":"2010","unstructured":"Garlet, G. P. Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J. Dent. Res. 89, 1349\u20131363 (2010).","journal-title":"J. Dent. Res."},{"key":"64_CR151","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/154411130201300104","volume":"13","author":"E Gemmell","year":"2002","unstructured":"Gemmell, E., Yamazaki, K. & Seymour, G. J. Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Crit. Rev. Oral. Biol. Med. 13, 17\u201334 (2002).","journal-title":"Crit. Rev. Oral. Biol. Med."},{"key":"64_CR152","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/1074-7613(95)90070-5","volume":"3","author":"Z Yao","year":"1995","unstructured":"Yao, Z. et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3, 811\u2013821 (1995).","journal-title":"Immunity"},{"key":"64_CR153","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.4049\/jimmunol.155.12.5483","volume":"155","author":"Z Yao","year":"1995","unstructured":"Yao, Z. et al. Human IL-17: a novel cytokine derived from T cells. J. Immunol. 155, 5483\u20135486 (1995).","journal-title":"J. Immunol."},{"key":"64_CR154","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1161\/01.STR.30.10.2174","volume":"30","author":"N Kostulas","year":"1999","unstructured":"Kostulas, N., Pelidou, S. H., Kivisa\u0308kk, P., Kostulas, V. & Link, H. Increased IL-1\u03b2, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 30, 2174\u20132179 (1999).","journal-title":"Stroke"},{"key":"64_CR155","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1172\/JCI5703","volume":"103","author":"S Kotake","year":"1999","unstructured":"Kotake, S. et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103, 1345\u20131352 (1999).","journal-title":"J. Clin. Invest."},{"key":"64_CR156","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington, L. E. et al. Interleukin 17\u2013producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123\u20131132 (2005).","journal-title":"Nat. Immunol."},{"key":"64_CR157","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","volume":"168","author":"C Parham","year":"2002","unstructured":"Parham, C. et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12R\u03b21 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699\u20135708 (2002).","journal-title":"J. Immunol."},{"key":"64_CR158","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni.2416","volume":"13","author":"Y Lee","year":"2012","unstructured":"Lee, Y. et al. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13, 991\u2013999 (2012).","journal-title":"Nat. Immunol."},{"key":"64_CR159","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/ni1539","volume":"8","author":"MJ McGeachy","year":"2007","unstructured":"McGeachy, M. J. et al. TGF-\u03b2 and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell\u2013mediated pathology. Nat. Immunol. 8, 1390\u20131397 (2007).","journal-title":"Nat. Immunol."},{"key":"64_CR160","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jaut.2012.03.003","volume":"39","author":"NM Moutsopoulos","year":"2012","unstructured":"Moutsopoulos, N. M. et al. Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. J. Autoimmun. 39, 294\u2013303 (2012).","journal-title":"J. Autoimmun."},{"key":"64_CR161","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cyto.2012.05.016","volume":"60","author":"L Zhu","year":"2012","unstructured":"Zhu, L. et al. Up-regulation of IL-23 p19 expression in human periodontal ligament fibroblasts by IL-1\u03b2 via concurrent activation of the NF-\u03baB and MAPKs\/AP-1 pathways. Cytokine 60, 171\u2013178 (2012).","journal-title":"Cytokine"},{"key":"64_CR162","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/jre.12100","volume":"49","author":"GS Himani","year":"2014","unstructured":"Himani, G. S., Prabhuji, M. L. V. & Karthikeyan, B. V. Gingival crevicular fluid and interleukin\u201023 concentration in systemically healthy subjects: their relationship in periodontal health and disease. J. Periodontal Res. 49, 237\u2013245 (2014).","journal-title":"J. Periodontal Res."},{"key":"64_CR163","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","volume":"50","author":"MJ McGeachy","year":"2019","unstructured":"McGeachy, M. J., Cua, D. J. & Gaffen, S. L. The IL-17 family of cytokines in health and disease. Immunity 50, 892\u2013906 (2019).","journal-title":"Immunity"},{"key":"64_CR164","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","volume":"15","author":"MM Fort","year":"2001","unstructured":"Fort, M. M. et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985\u2013995 (2001).","journal-title":"Immunity"},{"key":"64_CR165","doi-asserted-by":"publisher","first-page":"256ra134","DOI":"10.1126\/scitranslmed.3009124","volume":"6","author":"J Beale","year":"2014","unstructured":"Beale, J. et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci. Transl. Med. 6, 256ra134 (2014).","journal-title":"Sci. Transl. Med."},{"key":"64_CR166","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jaci.2018.03.019","volume":"142","author":"MA Kohanski","year":"2018","unstructured":"Kohanski, M. A. et al. Solitary chemosensory cells are a primary epithelial source of IL-25 in patients with chronic rhinosinusitis with nasal polyps. J. Allergy Clin. Immunol. 142, 460\u2013469. e467 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"64_CR167","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0968-0004(03)00067-7","volume":"28","author":"M Novatchkova","year":"2003","unstructured":"Novatchkova, M., Leibbrandt, A., Werzowa, J., Neub\u00fcser, A. & Eisenhaber, F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem. Sci. 28, 226\u2013229 (2003).","journal-title":"Trends Biochem. Sci."},{"key":"64_CR168","first-page":"ra63","volume":"2","author":"C Liu","year":"2009","unstructured":"Liu, C. et al. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci. Signal. 2, ra63 (2009).","journal-title":"Sci. Signal."},{"key":"64_CR169","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ni1439","volume":"8","author":"Y Qian","year":"2007","unstructured":"Qian, Y. et al. The adaptor Act1 is required for interleukin 17\u2013dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8, 247\u2013256 (2007).","journal-title":"Nat. Immunol."},{"key":"64_CR170","doi-asserted-by":"publisher","first-page":"14088","DOI":"10.1074\/jbc.M109.017129","volume":"285","author":"JR Karlsen","year":"2010","unstructured":"Karlsen, J. R., Borregaard, N. & Cowland, J. B. Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-\u03b1 is controlled by I\u03baB-\u03b6 but neither by C\/EBP-\u03b2 nor C\/EBP-\u03b4. J. Biol. Chem. 285, 14088\u201314100 (2010).","journal-title":"J. Biol. Chem."},{"key":"64_CR171","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4049\/jimmunol.177.1.36","volume":"177","author":"D Toy","year":"2006","unstructured":"Toy, D. et al. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177, 36\u201339 (2006).","journal-title":"J. Immunol."},{"key":"64_CR172","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/cmi.2015.105","volume":"13","author":"X Song","year":"2016","unstructured":"Song, X., He, X., Li, X. & Qian, Y. The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity. Cell. Mol. Immunol. 13, 418\u2013431 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"64_CR173","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen, S. L., Jain, R., Garg, A. V. & Cua, D. J. The IL-23\u2013IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14, 585\u2013600 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"64_CR174","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.immuni.2015.12.003","volume":"43","author":"DD Patel","year":"2015","unstructured":"Patel, D. D. & Kuchroo, V. K. Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity 43, 1040\u20131051 (2015).","journal-title":"Immunity"},{"key":"64_CR175","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/odi.12598","volume":"23","author":"L Abusleme","year":"2017","unstructured":"Abusleme, L. & Moutsopoulos, N. M. IL\u201017: overview and role in oral immunity and microbiome. Oral. Dis. 23, 854\u2013865 (2017).","journal-title":"Oral. Dis."},{"key":"64_CR176","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.chom.2016.10.001","volume":"20","author":"HR Conti","year":"2016","unstructured":"Conti, H. R. et al. IL-17 receptor signaling in oral epithelial cells is critical for protection against oropharyngeal candidiasis. Cell Host Microbe 20, 606\u2013617 (2016).","journal-title":"Cell Host Microbe"},{"key":"64_CR177","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1126\/science.1200439","volume":"332","author":"A Puel","year":"2011","unstructured":"Puel, A. et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332, 65\u201368 (2011).","journal-title":"Science"},{"key":"64_CR178","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/prd.12083","volume":"69","author":"C Zenobia","year":"2015","unstructured":"Zenobia, C. & Hajishengallis, G. Basic biology and role of interleukin\u201017 in immunity and inflammation. Periodontol 2000 69, 142\u2013159 (2015).","journal-title":"Periodontol 2000"},{"key":"64_CR179","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/0022034512446341","volume":"91","author":"T Okui","year":"2012","unstructured":"Okui, T., Aoki, Y., Ito, H., Honda, T. & Yamazaki, K. The presence of IL-17+\/FOXP3+ double-positive cells in periodontitis. J. Dent. Res. 91, 574\u2013579 (2012).","journal-title":"J. Dent. Res."},{"key":"64_CR180","doi-asserted-by":"publisher","first-page":"eaat0797","DOI":"10.1126\/scitranslmed.aat0797","volume":"10","author":"N Dutzan","year":"2018","unstructured":"Dutzan, N. et al. A dysbiotic microbiome triggers TH17 cells to mediate oral mucosal immunopathology in mice and humans. Sci. Transl. Med. 10, eaat0797 (2018).","journal-title":"Sci. Transl. Med."},{"key":"64_CR181","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.chom.2017.06.014","volume":"22","author":"E Xiao","year":"2017","unstructured":"Xiao, E. et al. Diabetes enhances IL-17 expression and alters the oral microbiome to increase its pathogenicity. Cell Host Microbe 22, 120\u2013128. e124 (2017).","journal-title":"Cell Host Microbe"},{"key":"64_CR182","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nri3908","volume":"15","author":"D Vestweber","year":"2015","unstructured":"Vestweber, D. How leukocytes cross the vascular endothelium. Nat. Rev. Immunol. 15, 692\u2013704 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"64_CR183","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.molmed.2019.02.010","volume":"25","author":"G Hajishengallis","year":"2019","unstructured":"Hajishengallis, G. & Chavakis, T. DEL-1-regulated immune plasticity and inflammatory disorders. Trends Mol. Med. 25, 444\u2013459 (2019).","journal-title":"Trends Mol. Med."},{"key":"64_CR184","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41590-018-0249-1","volume":"20","author":"I Kourtzelis","year":"2019","unstructured":"Kourtzelis, I. et al. DEL-1 promotes macrophage efferocytosis and clearance of inflammation. Nat. Immunol. 20, 40\u201349 (2019).","journal-title":"Nat. Immunol."},{"key":"64_CR185","doi-asserted-by":"publisher","first-page":"307ra155","DOI":"10.1126\/scitranslmed.aac5380","volume":"7","author":"J Shin","year":"2015","unstructured":"Shin, J. et al. DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates. Sci. Transl. Med. 7, 307ra155 (2015).","journal-title":"Sci. Transl. Med."},{"key":"64_CR186","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1126\/science.181845","volume":"193","author":"DA Morgan","year":"1976","unstructured":"Morgan, D. A., Ruscetti, F. W. & Gallo, R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193, 1007\u20131008 (1976).","journal-title":"Science"},{"key":"64_CR187","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1126\/science.1631559","volume":"257","author":"T Takeshita","year":"1992","unstructured":"Takeshita, T. et al. Cloning of the gamma chain of the human IL-2 receptor. Science 257, 379\u2013382 (1992).","journal-title":"Science"},{"key":"64_CR188","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1126\/science.7973658","volume":"266","author":"SM Russell","year":"1994","unstructured":"Russell, S. M. et al. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science 266, 1042\u20131045 (1994).","journal-title":"Science"},{"key":"64_CR189","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","volume":"38","author":"W Liao","year":"2013","unstructured":"Liao, W., Lin, J. X. & Leonard, W. J. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38, 13\u201325 (2013).","journal-title":"Immunity"},{"key":"64_CR190","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1902\/jop.2010.100425","volume":"82","author":"O Andrukhov","year":"2011","unstructured":"Andrukhov, O. et al. Serum cytokine levels in periodontitis patients in relation to the bacterial load. J. Periodontol. 82, 885\u2013892 (2011).","journal-title":"J. Periodontol."},{"key":"64_CR191","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle, E. & Massagu\u00e9, J. Transforming growth factor-\u03b2 signaling in immunity and cancer. Immunity 50, 924\u2013940 (2019).","journal-title":"Immunity"},{"key":"64_CR192","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032713-120257","volume":"32","author":"MA Travis","year":"2014","unstructured":"Travis, M. A. & Sheppard, D. TGF-\u03b2 activation and function in immunity. Annu. Rev. Immunol. 32, 51\u201382 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"64_CR193","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cell.2011.09.044","volume":"147","author":"E Trompouki","year":"2011","unstructured":"Trompouki, E. et al. Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration. Cell 147, 577\u2013589 (2011).","journal-title":"Cell"},{"key":"64_CR194","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cell.2011.08.050","volume":"147","author":"J Reddy","year":"2011","unstructured":"Reddy, J., Guenther, M. G., DeKoter, R. P. & Young, R. A. Master transcription factors determine cell-type-specific responses to TGF-b signaling. Cell 147, 565\u2013576 (2011).","journal-title":"Cell"},{"key":"64_CR195","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.4049\/jimmunol.172.9.5149","volume":"172","author":"MC Fantini","year":"2004","unstructured":"Fantini, M. C. et al. Cutting edge: TGF-\u03b2 induces a regulatory phenotype in CD4+ CD25\u2212 T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172, 5149\u20135153 (2004).","journal-title":"J. Immunol."},{"key":"64_CR196","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","volume":"29","author":"W Ouyang","year":"2011","unstructured":"Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A. & Hymowitz, S. G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29, 71\u2013109 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"64_CR197","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.1093\/emboj\/16.19.5894","volume":"16","author":"SV Kotenko","year":"1997","unstructured":"Kotenko, S. V. et al. Identification and functional characterization of a second chain of the interleukin\u201010 receptor complex. EMBO J. 16, 5894\u20135903 (1997).","journal-title":"EMBO J."},{"key":"64_CR198","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","volume":"174","author":"RDW Malefyt","year":"1991","unstructured":"Malefyt, R. D. W., Abrams, J., Bennett, B., Figdor, C. G. & De Vries, J. E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209\u20131220 (1991).","journal-title":"J. Exp. Med."},{"key":"64_CR199","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/mi.2016.47","volume":"10","author":"SM Coomes","year":"2017","unstructured":"Coomes, S. M. et al. CD4+ Th2 cells are directly regulated by IL-10 during allergic airway inflammation. Mucosal. Immunol. 10, 150\u2013161 (2017).","journal-title":"Mucosal. Immunol."},{"key":"64_CR200","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","volume":"34","author":"A Chaudhry","year":"2011","unstructured":"Chaudhry, A. et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34, 566\u2013578 (2011).","journal-title":"Immunity"},{"key":"64_CR201","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","volume":"147","author":"DF Fiorentino","year":"1991","unstructured":"Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M. & O\u2019Garra, A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815\u20133822 (1991).","journal-title":"J. Immunol."},{"key":"64_CR202","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.146.10.3444","volume":"146","author":"DF Fiorentino","year":"1991","unstructured":"Fiorentino, D. F. et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146, 3444\u20133451 (1991).","journal-title":"J. Immunol."},{"key":"64_CR203","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/ni.1791","volume":"10","author":"M Murai","year":"2009","unstructured":"Murai, M. et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 10, 1178\u20131184 (2009).","journal-title":"Nat. Immunol."},{"key":"64_CR204","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.4049\/jimmunol.0804165","volume":"183","author":"K-H Park-Min","year":"2009","unstructured":"Park-Min, K.-H. et al. IL-10 suppresses calcium-mediated costimulation of receptor activator NF-\u03baB signaling during human osteoclast differentiation by inhibiting TREM-2 expression. J. Immunol. 183, 2444\u20132455 (2009).","journal-title":"J. Immunol."},{"key":"64_CR205","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1189\/jlb.0108014","volume":"84","author":"CR Cardoso","year":"2008","unstructured":"Cardoso, C. R. et al. Characterization of CD4+ CD25+ natural regulatory T cells in the inflammatory infiltrate of human chronic periodontitis. J. Leukoc. Biol. 84, 311\u2013318 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"64_CR206","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1600-051X.2009.01390.x","volume":"36","author":"N Dutzan","year":"2009","unstructured":"Dutzan, N., Gamonal, J., Silva, A., Sanz, M. & Vernal, R. Over\u2010expression of forkhead box P3 and its association with receptor activator of nuclear factor\u2010\u03ba B ligand, interleukin (IL)\u201017, IL\u201010 and transforming growth factor\u2010\u03b2 during the progression of chronic periodontitis. J. Clin. Periodo. 36, 396\u2013403 (2009).","journal-title":"J. Clin. Periodo."},{"key":"64_CR207","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1177\/0022034510397838","volume":"90","author":"R Kobayashi","year":"2011","unstructured":"Kobayashi, R. et al. Induction of IL-10-producing CD4+ T-cells in chronic periodontitis. J. Dent. Res. 90, 653\u2013658 (2011).","journal-title":"J. Dent. Res."},{"key":"64_CR208","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1177\/154405910508400711","volume":"84","author":"T Nakajima","year":"2005","unstructured":"Nakajima, T. et al. Regulatory T-cells infiltrate periodontal disease tissues. J. Dent. Res. 84, 639\u2013643 (2005).","journal-title":"J. Dent. Res."},{"key":"64_CR209","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/mi.2015.136","volume":"9","author":"N Dutzan","year":"2016","unstructured":"Dutzan, N., Konkel, J. E., Greenwell-Wild, T. & Moutsopoulos, N. M. Characterization of the human immune cell network at the gingival barrier. Mucosal. Immunol. 9, 1163\u20131172 (2016).","journal-title":"Mucosal. Immunol."},{"key":"64_CR210","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cyto.2015.08.001","volume":"76","author":"B Wan","year":"2015","unstructured":"Wan, B. et al. Recombinant human interleukin-11 (IL-11) is a protective factor in severe sepsis with thrombocytopenia: a case-control study. Cytokine 76, 138\u2013143 (2015).","journal-title":"Cytokine"},{"key":"64_CR211","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1006\/cyto.1997.0208","volume":"9","author":"S Sonis","year":"1997","unstructured":"Sonis, S. et al. Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters. Cytokine 9, 605\u2013612 (1997).","journal-title":"Cytokine"},{"key":"64_CR212","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1172\/JCI6910","volume":"104","author":"WL Trepicchio","year":"1999","unstructured":"Trepicchio, W. L. et al. Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions. J. Clin. Invest. 104, 1527\u20131537 (1999).","journal-title":"J. Clin. Invest."},{"key":"64_CR213","doi-asserted-by":"publisher","first-page":"174764","DOI":"10.1155\/2012\/174764","volume":"2012","author":"OG Shaker","year":"2012","unstructured":"Shaker, O. G. & Ghallab, N. A. IL-17 and IL-11 G. C. F. levels in aggressive and chronic periodontitis patients: relation to PCR bacterial detection. Mediat. Inflamm. 2012, 174764 (2012).","journal-title":"Mediat. Inflamm."},{"key":"64_CR214","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1902\/jop.2012.110585","volume":"83","author":"ZY Ay","year":"2012","unstructured":"Ay, Z. Y. et al. The gingival crevicular fluid levels of interleukin\u201011 and interleukin\u201017 in patients with aggressive periodontitis. J. Periodontol. 83, 1425\u20131431 (2012).","journal-title":"J. Periodontol."},{"key":"64_CR215","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1601-0825.2008.01497.x","volume":"15","author":"ZY Ay","year":"2009","unstructured":"Ay, Z. Y., S\u00fct\u00e7\u00fc, R., Uskun, E., Bozkurt, F. Y. & Berker, E. The impact of the IL\u201011: IL\u201017 ratio on the chronic periodontitis pathogenesis: a preliminary report. Oral. Dis. 15, 93\u201399 (2009).","journal-title":"Oral. Dis."},{"key":"64_CR216","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1600-051X.2008.01212.x","volume":"35","author":"\u00d6\u00d6 Y\u00fccel","year":"2008","unstructured":"Y\u00fccel, \u00d6. \u00d6., Berker, E., Garibo\u011flu, S. & Otlu, H. Interleukin\u201011, interleukin\u20101\u03b2, interleukin\u201012 and the pathogenesis of inflammatory periodontal diseases. J. Clin. Periodontol. 35, 365\u2013370 (2008).","journal-title":"J. Clin. Periodontol."},{"key":"64_CR217","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1128\/JVI.70.2.1143-1153.1996","volume":"70","author":"O Devergne","year":"1996","unstructured":"Devergne, O. et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 70, 1143\u20131153 (1996).","journal-title":"J. Virol."},{"key":"64_CR218","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","volume":"16","author":"S Pflanz","year":"2002","unstructured":"Pflanz, S. et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 16, 779\u2013790 (2002).","journal-title":"Immunity"},{"key":"64_CR219","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S1074-7613(03)00298-X","volume":"19","author":"S Hamano","year":"2003","unstructured":"Hamano, S. et al. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19, 657\u2013667 (2003).","journal-title":"Immunity"},{"key":"64_CR220","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1097\/MIB.0000000000001274","volume":"23","author":"MH McLean","year":"2017","unstructured":"McLean, M. H. et al. Interleukin-27 is a potential rescue therapy for acute severe colitis through interleukin-10\u2013dependent, T-cell\u2013independent attenuation of colonic mucosal innate immune responses. Inflamm. Bowel Dis. 23, 1983\u20131995 (2017).","journal-title":"Inflamm. Bowel Dis."},{"key":"64_CR221","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1136\/ard.2007.083360","volume":"67","author":"W Niedbala","year":"2008","unstructured":"Niedbala, W. et al. Interleukin 27 attenuates collagen-induced arthritis. Ann. Rheum. Dis. 67, 1474\u20131479 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"64_CR222","doi-asserted-by":"publisher","first-page":"G568","DOI":"10.1152\/ajpgi.00329.2010","volume":"300","author":"T Sasaoka","year":"2010","unstructured":"Sasaoka, T. et al. Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G568\u2013G576 (2010).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"64_CR223","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/ni.2027","volume":"12","author":"L Codarri","year":"2011","unstructured":"Codarri, L. et al. ROR\u03b3t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12, 560\u2013567 (2011).","journal-title":"Nat. Immunol."},{"key":"64_CR224","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.4049\/jimmunol.1200131","volume":"189","author":"A Young","year":"2012","unstructured":"Young, A. et al. Cutting edge: suppression of GM-CSF expression in murine and human T cells by IL-27. J. Immunol. 189, 2079\u20132083 (2012).","journal-title":"J. Immunol."},{"key":"64_CR225","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/ni1537","volume":"8","author":"JS Stumhofer","year":"2007","unstructured":"Stumhofer, J. S. et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8, 1363\u20131371 (2007).","journal-title":"Nat. Immunol."},{"key":"64_CR226","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/ni1540","volume":"8","author":"DC Fitzgerald","year":"2007","unstructured":"Fitzgerald, D. C. et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27\u2013stimulated T cells. Nat. Immunol. 8, 1372\u20131379 (2007).","journal-title":"Nat. Immunol."},{"key":"64_CR227","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.4049\/jimmunol.180.5.2752","volume":"180","author":"M Batten","year":"2008","unstructured":"Batten, M. et al. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J. Immunol. 180, 2752\u20132756 (2008).","journal-title":"J. Immunol."},{"key":"64_CR228","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1902\/jop.2014.140293","volume":"86","author":"A Mitani","year":"2015","unstructured":"Mitani, A. et al. Increased expression of interleukin (IL)\u201035 and IL\u201017, but not IL\u201027, in gingival tissues with chronic periodontitis. J. Periodontol. 86, 301\u2013309 (2015).","journal-title":"J. Periodontol."},{"key":"64_CR229","doi-asserted-by":"publisher","first-page":"997","DOI":"10.5005\/jp-journals-10024-2372","volume":"19","author":"A Babaloo","year":"2018","unstructured":"Babaloo, A., Rahbar, M., Babaloo, Z., Ghasemi, S. & Amini, A. Evaluation of clinical periodontal indices and serum interleukin-27 by one-stage full-mouth disinfection and quadrant scaling and root planing in periodontitis. J. Contemp. Dent. Pr. 19, 997\u20131004 (2018).","journal-title":"J. Contemp. Dent. Pr."},{"key":"64_CR230","first-page":"428","volume":"22","author":"H Jia-Jia","year":"2013","unstructured":"Jia-Jia, H. et al. Comparison of the IL-27 level in gingival crevicular fluid of cross-quadrant and the upper and lower half-mouth subgingival scaling. Shanghai Kou Qiang Yi Xue 22, 428\u2013431 (2013).","journal-title":"Shanghai Kou Qiang Yi Xue"},{"key":"64_CR231","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ni.3103","volume":"16","author":"CA Nold-Petry","year":"2015","unstructured":"Nold-Petry, C. A. et al. IL-37 requires the receptors IL-18R\u03b1 and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nat. Immunol. 16, 354\u2013365 (2015).","journal-title":"Nat. Immunol."},{"key":"64_CR232","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1158\/2326-6066.CIR-17-0498","volume":"6","author":"D Sarhan","year":"2018","unstructured":"Sarhan, D. et al. Adaptive NK cells resist regulatory T-cell suppression driven by IL37. Cancer Immunol. Res. 6, 766\u2013775 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"64_CR233","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1177\/0022034519847443","volume":"98","author":"L Jing","year":"2019","unstructured":"Jing, L. et al. IL-37-and IL-35\/IL-37-producing plasma cells in chronic periodontitis. J. Dent. Res. 98, 813\u2013821 (2019).","journal-title":"J. Dent. Res."},{"key":"64_CR234","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05940-9","volume":"9","author":"S Offenbacher","year":"2018","unstructured":"Offenbacher, S. et al. GWAS for interleukin-1\u03b2 levels in gingival crevicular fluid identifies IL37 variants in periodontal inflammation. Nat. Commun. 9, 3686 (2018).","journal-title":"Nat. Commun."},{"key":"64_CR235","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrrheum.2015.171","volume":"12","author":"IB McInnes","year":"2016","unstructured":"McInnes, I. B., Buckley, C. D. & Isaacs, J. D. Cytokines in rheumatoid arthritis\u2014shaping the immunological landscape. Nat. Rev. Rheumatol. 12, 63\u201368 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"64_CR236","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.immuni.2019.03.017","volume":"50","author":"M Friedrich","year":"2019","unstructured":"Friedrich, M., Pohin, M. & Powrie, F. Cytokine networks in the pathophysiology of inflammatory bowel disease. Immunity 50, 992\u20131006 (2019).","journal-title":"Immunity"},{"key":"64_CR237","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","volume":"13","author":"V Ranganathan","year":"2017","unstructured":"Ranganathan, V., Gracey, E., Brown, M. A., Inman, R. D. & Haroon, N. Pathogenesis of ankylosing spondylitis\u2014recent advances and future directions. Nat. Rev. Rheumatol. 13, 359\u2013367 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"64_CR238","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes, M. A., Suarez-Farinas, M. & Krueger, J. G. Immunology of psoriasis. Annu. Rev. Immunol. 32, 227\u2013255 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"64_CR239","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","volume":"50","author":"BN Lambrecht","year":"2019","unstructured":"Lambrecht, B. N., Hammad, H. & Fahy, J. V. The cytokines of asthma. Immunity 50, 975\u2013991 (2019).","journal-title":"Immunity"},{"key":"64_CR240","doi-asserted-by":"publisher","first-page":"31","DOI":"10.12703\/P6-31","volume":"6","author":"N Vivar","year":"2014","unstructured":"Vivar, N. & Van Vollenhoven, R. F. Advances in the treatment of rheumatoid arthritis. F1000 Prime Rep. 6, 31 (2014).","journal-title":"F1000 Prime Rep."},{"key":"64_CR241","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1902\/jop.2008.070616","volume":"79","author":"JO Pers","year":"2008","unstructured":"Pers, J. O., Saraux, A., Pierre, R. & Youinou, P. Anti\u2013TNF\u2010\u03b1 immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis. J. Periodontol. 79, 1645\u20131651 (2008).","journal-title":"J. Periodontol."},{"key":"64_CR242","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1902\/jop.2009.090015","volume":"80","author":"Y Mayer","year":"2009","unstructured":"Mayer, Y., Balbir\u2010Gurman, A. & Machtei, E. E. Anti\u2010tumor necrosis factor\u2010alpha therapy and periodontal parameters in patients with rheumatoid arthritis. J. Periodontol. 80, 1414\u20131420 (2009).","journal-title":"J. Periodontol."},{"key":"64_CR243","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1902\/jop.2012.120009","volume":"84","author":"Y Mayer","year":"2013","unstructured":"Mayer, Y., Elimelech, R., Balbir\u2010Gurman, A., Braun\u2010Moscovici, Y. & Machtei, E. E. Periodontal condition of patients with autoimmune diseases and the effect of anti\u2010tumor necrosis factor\u2010\u03b1 therapy. J. Periodontol. 84, 136\u2013142 (2013).","journal-title":"J. Periodontol."},{"key":"64_CR244","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1902\/jop.2009.080447","volume":"80","author":"P Ortiz","year":"2009","unstructured":"Ortiz, P. et al. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J. Periodontol. 80, 535\u2013540 (2009).","journal-title":"J. Periodontol."},{"key":"64_CR245","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1034\/j.1600-051x.2002.290208.x","volume":"29","author":"T Oates","year":"2002","unstructured":"Oates, T., Graves, D. & Cochran, D. L. Clinical, radiographic and biochemical assessment of IL\u20101\/TNF\u2010\u03b1 antagonist inhibition of bone loss in experimental periodontitis. J. Clin. Periodontol. 29, 137\u2013143 (2002).","journal-title":"J. Clin. Periodontol."},{"key":"64_CR246","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/sj.bjp.0706979","volume":"150","author":"R Di Paola","year":"2007","unstructured":"Di Paola, R. et al. Effects of etanercept, a tumour necrosis factor\u2010\u03b1 antagonist, in an experimental model of periodontitis in rats. Br. J. Pharm. 150, 286\u2013297 (2007).","journal-title":"Br. J. Pharm."},{"key":"64_CR247","doi-asserted-by":"publisher","first-page":"9785","DOI":"10.1021\/acsnano.7b08976","volume":"12","author":"Z Liu","year":"2018","unstructured":"Liu, Z. et al. Nanofibrous spongy microspheres to distinctly release miRNA and growth factors to enrich regulatory T cells and rescue periodontal bone loss. ACS Nano 12, 9785\u20139799 (2018).","journal-title":"ACS Nano"}],"container-title":["International Journal of Oral Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41368-019-0064-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41368-019-0064-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41368-019-0064-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T03:19:25Z","timestamp":1721963965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41368-019-0064-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":247,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["64"],"URL":"https:\/\/doi.org\/10.1038\/s41368-019-0064-z","relation":{},"ISSN":["1674-2818","2049-3169"],"issn-type":[{"value":"1674-2818","type":"print"},{"value":"2049-3169","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"10 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}